Related Experiment Video
Updated: Oct 21, 2025

10:50
Purification and Analytics of a Monoclonal Antibody from Chinese Hamster Ovary Cells Using an Automated Microbioreactor System
Published on: May 1, 2019
14.9K
Multi-attribute method performance profile for quality control of monoclonal antibody therapeutics
Zhiqi Hao1, Benjamin Moore1, Chengfeng Ren1
1Analytical Development and Quality Control, 1 DNA Way, Genentech, South San Francisco, USA.
Journal of Pharmaceutical and Biomedical Analysis
|September 3, 2021
Summary
A multi-attribute method (MAM) using peptide mapping and mass spectrometry offers robust characterization of biotherapeutic proteins. This validated MAM workflow streamlines product quality control and supports efficient investigational product development.
Area of Science:
- Biopharmaceutical analysis
- Analytical chemistry
- Mass spectrometry
Background:
- Multi-attribute methods (MAM) are crucial for biotherapeutic protein characterization.
- Peptide mapping with high-resolution mass spectrometry provides detailed structural and variant information.
- Current methods for product release and stability testing can be time-consuming and require multiple assays.
Purpose of the Study:
- To define the desired performance profile for MAM in monoclonal antibody (mAb) product characterization.
- To address scientific challenges in MAM method validation for biotherapeutics.
- To develop and validate a platform MAM strategy for efficient product development and quality control.
Main Methods:
- Utilized peptide map analysis with high-resolution mass spectrometry for biotherapeutic protein characterization.
- Developed a platform method validation strategy for multiple mAb products with similar properties.
- Applied the Analytical Target Profile concept and regulatory guidelines for method validation design.
- Implemented a comprehensive system suitability control strategy for sample preparation, instrument operation, and data analysis.
Main Results:
- Demonstrated the capability of MAM to provide structural information, quantify variants/degradants, and detect lot-to-lot changes.
- Successfully applied a platform validation strategy to multiple mAb products, minimizing product-specific validation efforts.
- Showcased sufficient method performance for quantitative measurement of product variants and degradants.
- Validated MAM as a robust tool for analytical monitoring from early development to manufacturing QC.
Conclusions:
- A validated MAM workflow using peptide mapping and mass spectrometry is effective for comprehensive biotherapeutic protein characterization.
- The developed platform validation strategy enables efficient and reliable analytical monitoring of mAb products.
- MAM can serve as a single, powerful method for product release and stability testing, replacing multiple traditional assays.
Keywords:
Method validationMonoclonal antibodyMulti-attribute method (MAM)PrecisionQuality control (QC)System suitability testing
